Literature DB >> 8137482

Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.

T W Leung1, W Y Lau, S K Ho, M Chan, N W Leung, J Lin, C Metreweli, P J Johnson, A K Li.   

Abstract

A total of 51 patients with hepatocellular carcinoma (HCC) were studied to determine the tumour vascularity as determined by selective hepatic angiography (HAG) and by intrahepatic-arterial technetium-99m-labeled macroaggregated albumin (Tc99m-MAA) scan. The tumour vascularity was graded on the HAG films by an interventional radiologist using a scale ranging from 1 (hypovascular) to 4 (extremely hypervascular). The grades of vascularity on HAG were grade 1 in 5 patients, grade 2 in 13 patients, grade 3 in 24 patients and grade 4 in 9 patients. The tumour vascularity on scintigraphy was determined by quantifying the count rates over the tumour and normal liver areas by an analog/digital gamma-camera, and the resultant tumour-to-normal ratio (T/N ratio) gave a quantitative measure of the vascularity. The range of the T/N ratio was 0.9 to 11.1, with a median of 3.7. There was no correlation between the tumour vascularity grading on HAG and the T/N ratio on the Tc99m-MAA scan (Wilcoxon rank test, P = 0.83). Thus, we conclude that HAG cannot reveal the true vascularity nor reflect the T/N ratio in HCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137482     DOI: 10.1007/bf00686665

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  6 in total

1.  Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate.

Authors:  B N Gray; M A Burton; D K Kelleher; J Anderson; P Klemp
Journal:  J Surg Oncol       Date:  1989-11       Impact factor: 3.454

2.  Therapeutic aspects of radioisotopes in hepatobiliary malignancy.

Authors:  W Y Lau; A K Li
Journal:  Br J Surg       Date:  1992-07       Impact factor: 6.939

3.  Tolerance of the liver to the effects of Yttrium-90 radiation.

Authors:  B N Gray; M A Burton; D Kelleher; P Klemp; L Matz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-03       Impact factor: 7.038

4.  Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT).

Authors:  J W Gyves; H A Ziessman; W D Ensminger; J H Thrall; J E Niederhuber; J W Keyes; S Walker
Journal:  J Nucl Med       Date:  1984-09       Impact factor: 10.057

5.  Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II.

Authors:  J A Goldberg; M S Bradnam; D J Kerr; J H McKillop; R G Bessent; C S McArdle; N Willmott; W D George
Journal:  Nucl Med Commun       Date:  1987-12       Impact factor: 1.690

6.  Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma.

Authors:  W Y Lau; T W Leung; S Ho; M Chan; N W Leung; J Lin; C Metreweli; A K Li
Journal:  Br J Radiol       Date:  1994-02       Impact factor: 3.039

  6 in total
  2 in total

1.  The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.

Authors:  Mark Dunphy; Neeta Pandit-Taskar; Josef J Fox; Nancy Kemeny
Journal:  AJR Am J Roentgenol       Date:  2017-05-24       Impact factor: 3.959

2.  Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.

Authors:  M A D Vente; T C de Wit; M A A J van den Bosch; W Bult; P R Seevinck; B A Zonnenberg; H W A M de Jong; G C Krijger; C J G Bakker; A D van het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.